A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

This study assessed long-term immunogenicity and safety following 3 doses of AS04-adjuvanted human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) vaccine in females 10–14 years old. Girls included in the immunogenicity subset in the primary controlled, observer-blinded, randomized study (NC...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Tino F., Huang, Li-Min, Valencia, Alejandra, Panzer, Falko, Chiu, Cheng-Hsun, Decreux, Annabelle, Poncelet, Sylviane, Karkada, Naveen, Folschweiller, Nicolas, Lin, Lan, Dubin, Gary, Struyf, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746471/
https://www.ncbi.nlm.nih.gov/pubmed/31268383
http://dx.doi.org/10.1080/21645515.2019.1625644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746471/
https://www.ncbi.nlm.nih.gov/pubmed/31268383
http://dx.doi.org/10.1080/21645515.2019.1625644

Ejemplares similares